video corpo

Tumor Markers

Tumor Markers

Tumor Markers

Product catalog summary
Overview: The document provides information on tumor marker tests developed by Xiamen Biotime Biotechnology Co., Ltd. These tests are designed for easy use, with results available in 10 to 15 minutes and can be stored at room temperature. They are CE marked, indicating compliance with European standards.
Specifications: The tests cover a wide detection range and are qualified under CE ISO13485 standards. The tumor markers include CEA, AFP, tPSA, fPSA, PGI, PGII, and their combinations, with specific linear ranges for each marker.
Clinical Application: These tumor markers are used for various clinical applications, including cancer screening, diagnosis, therapy monitoring, early recurrence detection, differential diagnosis, and as prognostic and predictive indicators.
Associated Conditions: The document lists non-malignant conditions and associated cancers for each marker. For example, CEA is associated with colorectal cancer and other adenocarcinomas, while AFP is linked to hepatocarcinoma and germinal tumors.
Test Procedure: The procedure involves sampling, adding reagents, mixing, dropping the sample, and testing. The tests require small serum or plasma volumes, ranging from 10μL to 20μL.
Contact Information: The company is located in Xiamen, China, with contact details provided for further inquiries.
See more

Catalog excerpts

Tumor Markers-1

Tumor Markers Advantages Easy to Use, Results in 15 min. Room Temperature Storage. Wide Detection Range CE Marked Xiamen Biotime Biotechnology Co., Ltd. Address: 2F/3F/4F, No. 188, Pingcheng South Road, Haicang Street, Haicang District, Xiamen, Fujian, 361026, P. R. China

 Open the catalog to page 1
Tumor Markers-2

Clinical Application TUMOR MARKER Tumour marker can be used in a variety cancer patients. 1. For screening and diagnosis of cancer. 2. To monitor the effectiveness of therapy. Liver/Bile duct 3. For detection of early recurrence. 5. As prognostic and predictive indicators. PSA, FPSA Metastasis to bone Tumor Markers and Associated Disease Marker Associated Non-malignant Condition Associated Cancer IBD, hepatitis, cirrhosis, pancreatitis, gastritis, etc. Colorectal cancer, breast adenocarcinoma, lung viral hepatitis, liver injury, IBD Hepatocarcinoma, non-seminomatous, prostatitis, benign prostatic...

 Open the catalog to page 2

All Xiamen Biotime Biotechnology Co., Ltd. catalogs and technical brochures

  1. POCT SOLUTION

    2  Pages

  2. FLI-100

    2  Pages

  3. Renal Injury

    2  Pages

  4. HbA1c

    2  Pages

  5. HLC-100

    2  Pages

  6. BIOT-YG-I

    2  Pages

  7. 25(OH)-D

    2  Pages

  8. PCT

    2  Pages

  9. Sex Hormones

    2  Pages

  10. D-Dimer

    2  Pages

  11. Ferritin

    2  Pages

  12. TSH

    2  Pages

  13. Thyroid

    2  Pages

  14. FLI-600

    2  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.